These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31220775)

  • 1. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
    Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
    Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial.
    Knops RE; El-Chami MF; Marquie C; Nordbeck P; Quast ABE; Tilz RR; Brouwer TF; Lambiase PD; Cassidy CJ; Boersma LVA; Burke MC; Pepplinkhuizen S; de Veld JA; de Weger A; Bracke FALE; Manyam H; Probst V; Betts TR; Bijsterveld NR; Defaye P; Demming T; Elders J; Field DC; Ghani A; Golovchiner G; de Jong JSSG; Lewis N; Marijon E; Martin CA; Miller MA; Shaik NA; van der Stuijt W; Kuschyk J; Olde Nordkamp LRA; Arya A; Borger van der Burg AE; Boveda S; van Doorn DJ; Glikson M; Kaiser L; Maass AH; van Woerkens LJPM; Zaidi A; Wilde AAM; Smeding L
    Heart Rhythm; 2024 Jun; 21(6):836-844. PubMed ID: 38336193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
    Olde Nordkamp LR; Knops RE; Bardy GH; Blaauw Y; Boersma LV; Bos JS; Delnoy PP; van Dessel PF; Driessen AH; de Groot JR; Herrman JP; Jordaens LJ; Kooiman KM; Maass AH; Meine M; Mizusawa Y; Molhoek SG; van Opstal J; Tijssen JG; Wilde AA
    Am Heart J; 2012 May; 163(5):753-760.e2. PubMed ID: 22607851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients.
    Quast ABE; Baalman SWE; Van der Stuijt W; Wilde AAM; Knops RE
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2441-2447. PubMed ID: 31512339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score.
    Quast ABE; Baalman SWE; Brouwer TF; Smeding L; Wilde AAM; Burke MC; Knops RE
    Heart Rhythm; 2019 Mar; 16(3):403-410. PubMed ID: 30292861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the PRAETORIAN score in a large subcutaneous implantable cardioverter-defibrillator collective: Usefulness in clinical routine.
    Doldi F; Frommeyer G; Löher A; Ellermann C; Wolfes J; Güner F; Zerbst M; Engelke H; Korthals D; Reinke F; Eckardt L; Willy K
    Heart Rhythm; 2024 Jul; 21(7):1057-1063. PubMed ID: 38382685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study.
    Francia P; Biffi M; Adduci C; Ottaviano L; Migliore F; De Bonis S; Dello Russo A; De Filippo P; Viani S; Bongiorni MG; Caravati F; Lavalle C; Landolina ME; Pisanò E; Giorgi D; Lovecchio M; Valsecchi S; Diemberger I
    Europace; 2020 Dec; 22(12):1822-1829. PubMed ID: 33118017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E; Liebrich A; Michel U; Neuzner J; Pitschner H; Heisel A; Vester E; Ganschov U; Jung J
    Z Kardiol; 1999 Feb; 88(2):103-12. PubMed ID: 10209831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    Yamazaki K; Ishida Y; Sasaki S; Toyama Y; Nishizaki K; Kinjo T; Itoh T; Kimura M; Sakai S; Shikanai S; Sorimachi Y; Hamaura S; Tomita H
    J Cardiol; 2022 Nov; 80(5):482-486. PubMed ID: 35902323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.
    de Veld JA; Pepplinkhuizen S; van der Stuijt W; Quast ABE; Olde Nordkamp LRA; Kooiman KM; Wilde AAM; Smeding L; Knops RE
    Europace; 2023 Jul; 25(7):. PubMed ID: 37379530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing.
    Duffett S; El Hajjaji I; Manlucu J; Yee R
    Card Electrophysiol Clin; 2018 Mar; 10(1):119-125. PubMed ID: 29428133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator.
    Rudic B; Tülümen E; Fastenrath F; Akin I; Borggrefe M; Kuschyk J
    Heart Rhythm; 2020 Mar; 17(3):455-459. PubMed ID: 31669771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
    van der Stuijt W; Pepplinkhuizen S; de Veld JA; Quast ABE; van Halm VP; Bijsterveld NR; Olde Nordkamp LRA; Wilde AAM; Smeding L; Knops RE
    Int J Cardiol; 2024 Mar; 398():131639. PubMed ID: 38065323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study.
    D'Onofrio A; Russo V; Bianchi V; Cavallaro C; Leonardi S; De Vivo S; Vecchione F; Rago A; Ammendola E; Tavoletta V; Atripaldi L; Mocavero PE; Nigro G
    Europace; 2018 Sep; 20(FI2):f233-f239. PubMed ID: 29095967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.